CHEK1 and cancer: To better understand how cancers with high levels of replication stress respond, and then eventually stop responding to, Chk1 inhibition, several papers in this issue by Hunter et al. and Madgwick et al. use mouse model systems to probe the molecular consequences of losing Chk1 activity and how these systems circumvent Chk1 activity to develop resistance.